Sancilio Pharma To Present An Update On Research In Sickle Cell At Upcoming National SCDAA Convention
Sancilio Pharmaceuticals Company, Inc. (SPCI) will present an update on the research program in the field of sickle cell disease, at the National Sickle...
ORIC Pharma begins phase 1 study of novel GR antagonist with planned development for oncology
ORIC Pharmaceuticals, a privately held oncology company focused on the discovery and development of drugs to address treatment resistant cancers, announced that the first...
ViiV Healthcare announces positive results from phase III BRIGHTE study of fostemsavir in HTE patients with HIV-1 infection
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi Limited as shareholders, announced results from the phase III...
Boehringer Ingelheim achieves major breakthrough in canine cardiology
Dogs suffering from cardiovascular disease and related clinical signs will officially have an opportunity for a better and longer life, according to significant research...
Allergan Receives Approval for Ozurdex in China for the Treatment of Retinal Vein Occlusion (RVO)
Allergan plc announced that it has received an Imported Drugs License (IDL) from the Chinese FDA to market Ozurdex® (dexamethasone intravitreal implant 0.7 mg)...
Biogen And Eisai Expand Existing Collaboration Agreement To Develop And Commercialize Investigational for Alzheimer’s Disease Treatments
Eisai Co., Ltd. and Biogen Inc. announced that the companies have expanded their existing agreement to jointly develop and commercialize investigational Alzheimer's disease treatments....
Nicholas Shackley joins to Lead our Pharmaceutical Contract Development and Manufacturers Services Business
In this role Nicholas will lead Johnson Matthey's (JM) custom development and manufacturing offering to pharmaceutical and biotechnology customers who are developing novel therapies...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...